BioLife Solutions, Inc.

BLFSNASDAQHealthcare● Active

$26.10

$-0.55(-2.06%)

Market Cap$1.3B

P/E Ratio—

52W High$29.62

52W Low$17.86

Avg Volume511K

Open$26.78

Beta1.97

Cash on Hand Financials Revenue

BioLife Solutions, Inc. (BLFS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BLFS · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$88.9M▼ -15.0% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$33.0M

cashAndCashEquivalents

Short-Term Investments

$55.9M

shortTermInvestments

YoY Change vs Prior Year

-15.0%

vs prior fiscal year

Latest Quarter

$81.0M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$88.9MCash on Hand

Total Debt$17.9MTotal Debt

Net Cash / Net Debt+$71.0MNet Cash Position

Cash vs Debt Ratio

Cash 83%BioLife Solutions, Inc. cash as % of market cap: 6.97%% · MCap $1BDebt 17%

BioLife Solutions, Inc. has a net cash position of $71.0M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$88.9M − $17.9M = +$71.0M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

BLFS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

BLFS cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$88.9M-15.0%

Dec 31, 2024FY$104.6M+136.7%

Dec 31, 2023FY$44.2M-29.5%

Dec 31, 2022FY$62.7M-10.3%

Dec 31, 2021FY$69.9M-22.8%

BLFS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

BLFS vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

BioLife Solutions, Inc.YOU

BLFS

$88.9M$1B6.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

BioLife Solutions, Inc. (BLFS) cash on hand as of December 31, 2025 is $88.9M, comprising $33.0M in cash and cash equivalents (CCE) plus $55.9M in short-term investments — reported as BioLife Solutions, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as BioLife Solutions, Inc. cash reserves or cash position.

BioLife Solutions, Inc. annual cash on hand history shows decreased -15.0% in 2025: decreased -15.0% in 2025. BioLife Solutions, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

BioLife Solutions, Inc. carries total debt of $17.9M against cash of $88.9M, resulting in a net cash position of +$71.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

BLFS cash on hand · 5 questions

As of December 31, 2025, BioLife Solutions, Inc. (BLFS) has $88,927,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $33,038,000 in cash and cash equivalents (CCE) plus $55,889,000 in short-term investments. Latest quarter (March 31, 2026): $80,996,000. Data sourced from the annual 10-K filing via FMP.

BLFS cash on handBLFS cash reservesBLFS cash 2025how much cash does BLFS have

▸ Source: FMP /balance-sheet-statement · US GAAP · BioLife Solutions, Inc. · BioLife Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025